Clinical Trial Update: Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder [EARLY_Phase 1]

View source ↗

Summary

A dose-ranging Phase 1 trial evaluating creatine augmentation for adolescent females with treatment-resistant major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Perry Renshaw | Conditions: Major Depressive Disorder | EARLY_Phase 1 | Status: COMPLETED